GENEDX HOLDINGS (WGS)
(Delayed Data from NSDQ)
$40.62 USD
+3.78 (10.26%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $40.63 +0.01 (0.02%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth B Momentum C VGM
GeneDx Holdings Corp. (WGS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$40.83 | $50.00 | $32.00 | 10.83% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for GeneDx Holdings Corp. comes to $40.83. The forecasts range from a low of $32.00 to a high of $50.00. The average price target represents an increase of 10.83% from the last closing price of $36.84.
Analyst Price Targets (6 )
Broker Rating
GeneDx Holdings Corp. currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, three are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 1.80 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/27/2024 | Wells Fargo Securities | Brandon Couillard | Not Available | Hold |
7/31/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
7/17/2024 | Goldman Sachs | Matthew Sykes | Hold | Hold |
7/10/2024 | Craig-Hallum | William B Bonello | Not Available | Strong Buy |
6/26/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
6/3/2024 | Not Identified | Not Identified | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 6 |
Average Target Price | $40.83 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 156 of 253 |
Current Quarter EPS Est: | -0.19 |
WGS FAQs
GeneDx Holdings Corp. (WGS) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for GeneDx Holdings Corp. (WGS) is $40.83. The current on short-term price targets is based on 1 reports.
The forecasts for GeneDx Holdings Corp. (WGS) range from a low of $32 to a high of $50. The average price target represents a increase of $10.83 from the last closing price of $36.84.
The current UPSIDE for GeneDx Holdings Corp. (WGS) is 10.83%
Based on short-term price targets offered by six analysts, the average price target for GeneDx Holdings Corp. comes to $40.83. The forecasts range from a low of $32.00 to a high of $50.00. The average price target represents an increase of 10.83% from the last closing price of $36.84.